Dihydroartemisinin suppresses proliferation, migration, the Wnt/β-catenin pathway and EMT via TNKS in gastric cancer

Oncol Lett 22: Article no. 688, 2021; DOI: 10.3892/ol.2021.12949

Following the publication of this article, the authors have reaized that Table II was printed containing certain numerical errors, although these were not significant enough to have affected the statistical results.

The corrected version of Table II is shown on the next page, and the corrected data (concerning the ‘Depth of invasion’, Lymph metastasis’, ‘TNM stage’ and ‘Survival status’ data rows) are highlighted in bold. The authors are grateful to the Editor of Oncology Letters for allowing them the opportunity to publish this corrigendum, and all the authors agree to this corrigendum. Furthermore, the authors apologize to the readership for any inconvenience caused.

Table II.

Association between TNKS expression and the clinicopathological characteristics of patients with gastric cancer (n=87).

		TNKS expression
Characteristic	Total (n=87)	Positive, % (n=61)	Negative, % (n=26)	χ2	P-value
Sex
Male	42	28 (66.7)	14 (33.3)	0.461	0.497
Female	45	33 (73.3)	12 (26.7)
Age, years
<60	43	32 (74.4)	11 (25.6)	0.752	0.386
≥60	44	29 (65.9)	15 (34.1)
BMI
<24	27	17 (63.0)	10 (37.0)	0.978	0.613
24-27.9	31	23 (74.2)	8 (25.8)
≥28	29	21 (72.4)	8 (27.6)
Smoking
No	46	33 (71.7)	13 (28.3)	0.123	0.726
Yes	41	28 (68.3)	13 (31.7)
Drinking
No	39	24 (61.5)	15 (38.5)	2.481	0.115
Yes	48	37 (77.1)	11 (22.9)
Helicobacter pylori infection
No	54	37 (68.5)	17 (31.5)	0.173	0.677
Yes	33	24 (72.7)	9 (27.3)
Depth of invasion
T1/T2	39	22 (56.4)	17 (43.6)	6.336	0.012a
T3/T4	48	39 (81.2)	9 (18.8)
Lymph metastasis
N0	26	12 (46.2)	14 (53.8)	10.160	0.001b
N1/N2/N3	61	49 (80.3)	12 (19.7)
TNM stage
Ⅰ-II	40	23 (57.5)	17 (42.5)	5.623	0.018a
III-IV	47	38 (80.9)	9 (19.1)
Survival status
Dead	33	31 (93.9)	2 (6.1)	14.402	<0.001c
Alive	54	30 (55.6)	24 (44.4)

^aP<0.05;

^bP<0.01;

^cP<0.001. TNKS, Tankyrases; TNM, tumor-node-metastasis.